Hello and welcome to my Nuzzel newsletter!
(Senior reporter at @ProPublica, past president of @ahcj, hopeful Detroit Lions fan, Columbia journ prof. Dad and husband. firstname.lastname@example.org)
WASHINGTON — Drug makers and their middlemen counterparts spent the first three months of the 116th Congress successfully dodging hard blows from members of Congress over the high cost of prescription drugs. That all changed Wednesday.
Decisions by two of the world's biggest insulin producers to offer bigger discounts on drugs used by millions of diabetics are raising questions from Congress about whether the companies could have done so sooner. On Wednesday, French drugmaker…
Tampa Bay Times
– Apr 10, 9:27 AM
Sandra Vázquez received the letter in the beginning of January. The president of the Johns Hopkins Health System was writing to say there had been “failures” in her son's care at All Children's Hospital in 2017. He asked for a…
The Washington Post
– Apr 10, 1:27 PM
The appeals, in cases challenging Kentucky and Arkansas's Medicaid work requirements, come two weeks after a federal judge in Washington issued opinions that President Trump's top health aides had been “arbitrary and capricious” in…
Gilead Sciences (GILD) is preparing to lay off approximately 20% of its sales force now that two of its older drugs have lost patent protection and face competition from lower-priced generics, STAT has learned. The decision to cut 150 long-tenured…
Last month, I decided to try an experiment with my media diet. Usually, in the morning, I skim e-mail newsletters in my in-box, scroll through my Twitter feed, and peruse the news apps on my phone; later, in the office, I tap through my…